Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BSX | Common Stock | Options Exercise | $0 | +923 | +4.22% | $0.00 | 22.8K | Feb 15, 2022 | Direct | F1 |
transaction | BSX | Common Stock | Tax liability | -$12K | -272 | -1.19% | $44.01 | 22.5K | Feb 15, 2022 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BSX | Deferred Stock Units | Options Exercise | $0 | -923 | -49.95% | $0.00 | 925 | Feb 15, 2022 | Common Stock | 923 | Direct | F1, F2 | |
transaction | BSX | Restricted Stock Units | Award | $0 | +6.22K | $0.00 | 6.22K | Feb 16, 2022 | Common Stock | 6.22K | Direct | F3, F4 | ||
transaction | BSX | Stock Option (Right to Buy) | Award | $0 | +17.8K | $0.00 | 17.8K | Feb 16, 2022 | Common Stock | 17.8K | $44.19 | Direct | F5 |
Id | Content |
---|---|
F1 | Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |
F2 | Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant. |
F3 | Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |
F4 | Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant. |
F5 | Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant. |
eddypoa.txt